These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8220167)

  • 1. Vasoactive intestinal peptide: involvement of calmodulin and catalytic antibodies.
    Said SI
    Neurochem Int; 1993 Sep; 23(3):215-9. PubMed ID: 8220167
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasoactive intestinal peptide: role of calmodulin and catalytic antibodies.
    Bolin DR
    Neurochem Int; 1993 Sep; 23(3):221-7. PubMed ID: 8220168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide: its interactions with calmodulin and catalytic antibodies.
    Paul S; Ebadi M
    Neurochem Int; 1993 Sep; 23(3):197-214. PubMed ID: 8220166
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasoactive intestinal polypeptide (VIP) in lung function and disease.
    Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1525-31. PubMed ID: 1687288
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal polypeptide (VIP) in asthma.
    Said SI
    Ann N Y Acad Sci; 1991; 629():305-18. PubMed ID: 1683200
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between catecholamines and vasoactive intestinal peptide in cultured astrocytes.
    Hansson E; Rönnbäck L
    Neuropharmacology; 1988 Mar; 27(3):295-300. PubMed ID: 2836754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
    Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
    Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide induces both tyrosine hydroxylase activity and tetrahydrobiopterin biosynthesis in PC12 cells.
    Anastasiadis PZ; Bezin L; Gordon LJ; Imerman B; Blitz J; Kuhn DM; Levine RA
    Neuroscience; 1998 Sep; 86(1):179-89. PubMed ID: 9692753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACAP/VIP receptor subtypes, signal transducers, and effectors in pituitary cells.
    Hezareh M; Journot L; Bépoldin L; Schlegel W; Rawlings SR
    Ann N Y Acad Sci; 1996 Dec; 805():315-27; discussion 327-8. PubMed ID: 8993413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple receptors for PACAP and VIP.
    Harmar T; Lutz E
    Trends Pharmacol Sci; 1994 Apr; 15(4):97-9. PubMed ID: 7912462
    [No Abstract]   [Full Text] [Related]  

  • 12. [The lung and neuropeptides].
    Kitamura S
    Kokyu To Junkan; 1989 May; 37(5):477-82. PubMed ID: 2473504
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells.
    Mangels LA; Gnegy ME
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):103-10. PubMed ID: 1347631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M; Sun W; Leceta J; Ganea D
    J Immunol; 1999 Oct; 163(8):4213-23. PubMed ID: 10510358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.
    Laburthe M; Prieto JC; Amiranoff B; Dupont C; Hui Bon Hoa D; Rosselin G
    Eur J Biochem; 1979 May; 96(2):239-48. PubMed ID: 88368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vasoactive intestinal peptide and other neuropeptides in the regulation of the immune response in vitro and in vivo.
    Stanisz AM; Scicchitano R; Bienenstock J
    Ann N Y Acad Sci; 1988; 527():478-85. PubMed ID: 3291699
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of calmodulin in the regulation of adenylate cyclase activity in guinea-pig enterocytes.
    Pinkus LM; Sulimovici S; Susser FI; Roginsky MS
    Biochim Biophys Acta; 1983 Jul; 762(4):552-9. PubMed ID: 6191780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
    Hayez N; Harfi I; Lema-Kisoka R; Svoboda M; Corazza F; Sariban E
    J Neuroimmunol; 2004 Apr; 149(1-2):167-81. PubMed ID: 15020077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins.
    Maggi CA; Giachetti A; Dey RD; Said SI
    Physiol Rev; 1995 Apr; 75(2):277-322. PubMed ID: 7724664
    [No Abstract]   [Full Text] [Related]  

  • 20. Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: functional convergence with contrasting morphology.
    Magistretti PJ; Morrison JH
    Neuroscience; 1988 Feb; 24(2):367-78. PubMed ID: 2834663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.